Related Experiment Video
Updated: Aug 10, 2026
06:34
Operation of a 25 KWth Calcium Looping Pilot-plant with High Oxygen Concentrations in the Calciner
Published on: October 25, 2017
Business coalitions: new tactic in cost control
Trustee : the Journal for Hospital Governing Boards
|January 11, 1982
Summary
Business coalitions are emerging to control healthcare expenses. Stakeholders like providers, payers, businesses, and labor are committed to supporting these voluntary efforts.
Area of Science:
- Health economics
- Healthcare management
- Public health policy
Background:
- Rising healthcare costs pose a significant challenge to businesses and individuals.
- Traditional cost-containment strategies have yielded limited success.
- The need for collaborative approaches in healthcare cost reduction is increasingly recognized.
Purpose of the Study:
- To introduce the concept and formation of business coalitions aimed at healthcare cost containment.
- To outline the initial commitments and participation of key stakeholders in these coalitions.
- To establish a baseline understanding of these emerging initiatives.
Main Methods:
- Descriptive analysis of the formation and stated goals of business coalitions.
- Identification of participating stakeholder groups (providers, payers, business, labor).
- Review of pledges and commitments made by stakeholders.
Main Results:
- Business coalitions are in the early stages of development.
- Stakeholders have pledged support for voluntary coalition efforts.
- Cross-sectoral participation (providers, payers, business, labor) is evident.
Conclusions:
- Voluntary business coalitions represent a novel approach to addressing healthcare costs.
- Early stakeholder commitment suggests potential for future collaboration.
- The long-term effectiveness of these coalitions remains to be determined.
Related Concept Videos
00:51Energy Budgets and Reproductive Strategies
Organisms must balance energy intake with the energy required for growth, maintenance, and reproduction. These trade-offs result in a variety of survivorship and reproductive strategies, including semelparity and iteroparity. Semelparous species reproduce only once in their lifetime, often investing most available resources into that single reproductive event. Iteroparous species, by contrast, reproduce multiple times over their lifetimes, typically allocating fewer resources to any single...
01:26Methods Of Healthcare Delivery System
At the different levels of the healthcare system, we see varying methods of healthcare used. These methods include managed care systems, case management, and primary healthcare.
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is limited...
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is limited...
01:30Health Information Technology and Healthcare Information System
Health Information Technology (HIT)
Health Information Technology, commonly called HIT, integrates advanced information systems and technology in healthcare settings. Its primary functions include:
Health Information Technology, commonly called HIT, integrates advanced information systems and technology in healthcare settings. Its primary functions include:
01:03Drug Control Governance: Regulatory Bodies and Their Impact
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with a...